Pneumocystis pneumonia in HIV-1-infected patients

被引:18
|
作者
Shibata, Satoshi [1 ]
Kikuchi, Toshiaki [2 ]
机构
[1] Niigata City Gen Hosp, Dept Resp Med, Niigata 9501197, Japan
[2] Niigata Univ, Grad Sch Med & Dent Sci, Dept Resp Med & Infect Dis, Chuo Ku, 1-757 Asahimachidori, Niigata 9518510, Japan
基金
日本学术振兴会;
关键词
Pneumocystis pneumonia; Acquired immunodeficiency syndrome; Human immunodeficiency virus; Opportunistic infection; ACQUIRED-IMMUNODEFICIENCY-SYNDROME; BETA-D-GLUCAN; CARINII-PNEUMONIA; TRIMETHOPRIM-SULFAMETHOXAZOLE; RANDOMIZED-TRIAL; AEROSOLIZED PENTAMIDINE; PRIMARY PROPHYLAXIS; JIROVECII PNEUMONIA; DOUBLE-BLIND; AIDS;
D O I
10.1016/j.resinv.2019.01.009
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Pneumocystis pneumonia (PCP) is an opportunistic disease that mainly affects patients with a deficiency of cell-mediated immunity, especially acquired immunodeficiency syndrome (AIDS). The incidence of PCP in these patients has declined substantially owing to the widespread use of antiretroviral therapy and PCP prophylaxis. However, PCP is still a major AIDS-related opportunistic infection, particularly in patients with advanced immunosuppression in whom human immunodeficiency virus type 1 (HIV-1) infection remains undiagnosed or untreated. The clinical manifestations, diagnosis, treatment, and prevention of PCP in patients with HIV-1 infection are addressed in this review. (C) 2019 The Japanese Respiratory Society. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:213 / 219
页数:7
相关论文
共 50 条
  • [41] Atovaquone suspension for treatment of Pneumocystis carinii pneumonia in HIV-infected patients
    Rosenberg, DM
    McCarthy, W
    Slavinsky, J
    Chan, CKN
    Montaner, J
    Braun, J
    Dohn, MN
    Caldwell, PT
    [J]. AIDS, 2001, 15 (02) : 211 - 214
  • [42] Increasing risk of Pneumocystis pneumonia among newly diagnosed HIV-infected patients with Pneumocystis colonization
    Lee, Nan-Yao
    Li, Ming-Chi
    Chen, Po-Lin
    Li, Chia-Wen
    Ko, Wen-Chien
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 50 : S95 - S95
  • [43] HIV-2-INFECTED PATIENTS SURVIVE LONGER THAN HIV-1-INFECTED PATIENTS
    WHITTLE, H
    MORRIS, J
    TODD, J
    CORRAH, T
    SABALLY, S
    BANGALI, J
    NGOM, PT
    ROLFE, M
    WILKINS, A
    [J]. AIDS, 1994, 8 (11) : 1617 - 1620
  • [44] Pneumocystis jiroveci pneumonia: comparative study of cases in HIV-infected patients and immunocompromised non-HIV-infected patients
    Ceron, Ines
    Rabagliati, Ricardo
    Langhaus, Javiera
    Silva, Felipe
    Guzman, Ana M.
    Lagos, Marcela
    [J]. REVISTA CHILENA DE INFECTOLOGIA, 2014, 31 (04): : 417 - 424
  • [45] Dysregulation of β-chemokines in the lungs of HIV-1-infected patients
    Aung, H
    McKenna, SM
    Ketoff, NR
    Jones, L
    Wu, M
    Hejal, R
    Rich, EA
    Toossi, Z
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2001, 26 (04) : 305 - 314
  • [46] Effectiveness of ezetimibe on hyperlipidaemia in HIV-1-infected patients
    von Lintig, FC
    Lee, D
    Patel, P
    Epp, J
    Barber, R
    Mathews, WC
    [J]. ANTIVIRAL THERAPY, 2004, 9 (06) : L48 - L49
  • [47] Indinavir in cerebrospinal fluid of HIV-1-infected patients
    Ståhle, L
    Martin, C
    Svensson, JO
    Sönnerborg, A
    [J]. LANCET, 1997, 350 (9094): : 1823 - 1823
  • [48] Sexually transmitted diseases in HIV-1-infected patients
    Medland, N
    [J]. LANCET, 2001, 357 (9267): : 1533 - 1534
  • [49] Spinal cord disorders in HIV-1-infected patients
    Eyer-Silva, WA
    Auto, I
    Pinto, JFC
    de Sá, CAM
    [J]. INFECTIOUS DISEASES IN CLINICAL PRACTICE, 1999, 8 (03) : 127 - 136
  • [50] Association of osteonecrosis and osteoporosis in HIV-1-infected patients
    Fessel, W. Jeffrey
    Chau, Quyen
    Leong, Davis
    [J]. AIDS, 2011, 25 (15) : 1877 - 1880